semaglutide weight loss with ongoing nurse support Viva SEMAGLUTIDE AND TIRZEPATIDE INJECTIONS FOR

These medications mimic the action of the GLP-1 hormone, which is naturally released in the small intestine after meals

The American Heart Association has explicitly supported these medications for mitigating outcomes associated with atherosclerotic cardiovascular disease, including myocardial infarction, stroke, and cardiovascular death (Marx et al

- WHO SHOULD USE THEM

Dugo vremena sam imao visok krvni pritisak, a isto tako dugo vremena i uzimam lekove za hipertenziju

Its a GLP-1 receptor agonist, a class of medications that mimic the hormone GLP-1

Glucagon receptor agonism drives significant increases in energy expenditure and hepatic fat oxidation effects that are largely independent of the insulin secretion and appetite pathways activated by GLP-1R and GIPR